Literature DB >> 1286162

Induction of apoptosis--new targets for cancer chemotherapy.

C Dive1, C A Evans, A D Whetton.   

Abstract

Many anticancer agents induce an active cell death process, apoptosis, in sensitive tumour cells. Elucidation of molecular mechanisms underlying apoptosis may shed light on why some tumour cells survive chemotherapy, and may identify new targets for anticancer agents whose effects are not tightly linked to proliferative status. The signal transduction events which initiate apoptosis are unclear. A change in cytosolic calcium is generally assumed to be a key signal for apoptosis although the evidence for this is not conclusive. Other putative signal transducers which may modulate apoptosis are protein kinase C and cAMP. Genes which induce apoptosis in response to such signals are largely unidentified, but certain oncogenes, notably bcl-2, act to delay or suppress apoptosis in several cell types.

Entities:  

Mesh:

Year:  1992        PMID: 1286162

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  17 in total

1.  Comparison of in situ methods to assess DNA cleavage in apoptotic cells in patients with breast cancer.

Authors:  P N Mainwaring; P A Ellis; S Detre; I E Smith; M Dowsett
Journal:  J Clin Pathol       Date:  1998-01       Impact factor: 3.411

2.  Design of a functional cyclic HSV1-TK reporter and its application to PET imaging of apoptosis.

Authors:  Zhe Wang; Fu Wang; Naoki Hida; Dale O Kiesewetter; Jie Tian; Gang Niu; Xiaoyuan Chen
Journal:  Nat Protoc       Date:  2015-04-30       Impact factor: 13.491

3.  Necrosis and apoptosis in the gastrointestinal tract.

Authors:  A J Watson
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

4.  Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32.

Authors:  P N Adjei; S H Kaufmann; W Y Leung; F Mao; G J Gores
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

Review 5.  Cell and molecular mechanisms of pathogenesis and treatment of cancer.

Authors:  D A Rew
Journal:  Postgrad Med J       Date:  1998-02       Impact factor: 2.401

6.  Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol.

Authors:  L Milas; N R Hunter; B Kurdoglu; K A Mason; R E Meyn; L C Stephens; L J Peters
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

7.  1-beta-D-arabinofuranosylcytosine-, mitoxantrone-, and paclitaxel-induced apoptosis in HL-60 cells: improved method for detection of internucleosomal DNA fragmentation.

Authors:  S Ray; V Ponnathpur; Y Huang; C Tang; M E Mahoney; A M Ibrado; G Bullock; K Bhalla
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 8.  Multilevel therapeutic targeting by topoisomerase inhibitors.

Authors:  P J Smith; S Souès
Journal:  Br J Cancer Suppl       Date:  1994-09

9.  DNA fragmentation as a consequence of cell cycle traverse in doxorubicin- and idarubicin-treated human lymphoma cells.

Authors:  P J Smith; C Rackstraw; F Cotter
Journal:  Ann Hematol       Date:  1994       Impact factor: 3.673

10.  A cyclic HSV1-TK reporter for real-time PET imaging of apoptosis.

Authors:  Fu Wang; Zhe Wang; Naoki Hida; Dale O Kiesewetter; Ying Ma; Kai Yang; Pengfei Rong; Jimin Liang; Jie Tian; Gang Niu; Xiaoyuan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.